Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS1 | P29475 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 11/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.32 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28205269 | 1.00 | NOS3 (0.37) | NOS3NOS1ACACBFFAR1PTPN5 | |
| SCHEMBL28205268 | 1.00 | NOS3 (0.37) | NOS3NOS1ACACBFFAR1PTPN5 | |
| SCHEMBL9340095 | 0.87 | NOS3 (0.41) | NOS3NOS1ACACBFFAR1PTPN5 | |
| SCHEMBL28148769 | 0.81 | CYP3A4 (0.34) | ACACBFFAR1 | |
| SCHEMBL28205264 | 0.81 | CYP3A4 (0.34) | ACACBFFAR1 | |
| SCHEMBL28148773 | 0.81 | CYP3A4 (0.34) | ACACBFFAR1 | |
| SCHEMBL28039510 | 0.81 | FFAR1 (0.43) | NOS3NOS1ACACBFFAR1 | |
| SCHEMBL28039509 | 0.81 | FFAR1 (0.43) | NOS3NOS1ACACBFFAR1 | |
| SCHEMBL28039760 | 0.81 | FFAR1 (0.43) | NOS3NOS1ACACBFFAR1 | |
| SCHEMBL28205844 | 0.80 | ACACB (0.31) | ACACBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105073710-B | Novel hydroxamic acid derivative or salt thereof | 富山化学工业株式会社 | 2018-02-16 | — | — | CN | disclosed |